Is Ketamine FDA-Approved for Depression?
Watch: Is Ketamine FDA Approved for Depression? An Honest Answer About Off-Label Use

From the TMS Therapy Centers Colorado video series. Educational only; not medical advice.
People searching for ketamine treatment in Denver often ask one question before anything else: is ketamine FDA-approved for depression? A straight answer is more useful than a vague one. Ketamine is not FDA-approved for depression. It is used for that purpose off-label, under a physician's judgment. A related medication, SPRAVATO, is FDA-approved. The rest of this article explains what that difference means in practice, why it affects cost and structure, and how to weigh the options.
What "off-label" actually means
Ketamine has been a regulated medication for more than half a century, and that long record is where much of its safety data comes from. When research began showing that low doses might relieve depression, clinicians started prescribing it for that purpose.
Off-label prescribing is a routine and legal practice in medicine. Once a medication is on the market, a physician may prescribe it for a condition outside its official labeling when there is reasonable evidence and clinical judgment supporting the decision. Many people have taken a medication off-label without ever knowing it.
What off-label does mean is specific. No company has taken ketamine through the formal trials and review that would produce a depression indication. As a result, dosing, frequency, and route are set by the treating physician based on the research and on the individual, rather than by a label. That places more weight on the physician's training, on careful screening, and on monitoring during every session.
What approval means, and what it does not
Approval means a specific evidence package was reviewed by the FDA for a specific condition and population. Off-label means the evidence lives in the research literature and in clinical experience rather than on a label. Neither word says whether a treatment will work for a particular person. They describe the regulatory path, and they describe who is responsible for defining the protocol.
The exception: SPRAVATO
The one exception in this family is SPRAVATO. Esketamine, one of the two molecules that make up ketamine, went through the formal approval process. SPRAVATO is FDA-approved for treatment-resistant depression in adults, and it is FDA-approved for major depressive disorder with acute suicidal thoughts or actions. It is also approved as monotherapy for treatment-resistant depression.
SPRAVATO is given in a certified setting with monitoring, following a defined protocol. You can read how it works on our SPRAVATO page or in our guide to what SPRAVATO is.
If you are in crisis, call or text 988 (Suicide and Crisis Lifeline) or go to the nearest emergency room.
Why the difference matters for cost and coverage
Because SPRAVATO went through formal approval, it follows a defined protocol and is generally covered by insurance when coverage criteria are met. Ketamine therapy, which is given under a physician's own protocol, is generally self-pay. This is one of the practical reasons people who qualify for SPRAVATO often begin there.
That is a generalization, not a promise about any one plan. Coverage depends on the plan, the diagnosis, and what has already been tried. This is why benefits verification matters. You can read more about how we approach that on our insurance page, and about ketamine pricing in our article on ketamine therapy cost.
Two different structures
- SPRAVATO: a labeled protocol, given in a certified setting, with required monitoring and observation after each session.
- Ketamine therapy: a physician-designed protocol, off-label, with the route, dose, and schedule chosen for the individual and adjusted as the course goes on.
Both involve supervision. The difference is who defines the framework: a label in one case, a physician's clinical judgment in the other.
How to weigh your options
The question "is it approved?" is a good starting point, but it is not the whole decision. A person weighing options needs an evaluation that says clearly what is approved, what is off-label, and why one or the other fits their situation.
Questions worth asking any clinic
- Who evaluates me, and is that person a psychiatrist?
- Is each option described honestly as approved or off-label?
- Who supervises sessions, and what monitoring happens?
- What happens if the first option does not help enough?
- How are insurance benefits handled before treatment starts?
A clinic that answers these plainly is behaving the way a medical practice should. A clinic that blurs the line between approved and off-label is giving you less information than you need.
Fit matters more than the label
Some people qualify for SPRAVATO and will start there. Some are better served by ketamine therapy. Some are better served by TMS, which involves no medication at all and is FDA-cleared for major depressive disorder. Some need their medications adjusted first. An evaluation sorts these paths out, and it is reasonable to expect that the sorting is explained in plain language.
If you want to compare the two esketamine-related options directly, our article on SPRAVATO vs TMS lays out how they differ, and our page on treatment-resistant depression explains when people usually begin considering them.
What to expect from a responsible ketamine program
Because ketamine for depression is off-label, the quality of the program matters even more. A responsible program generally includes a physician-led evaluation, screening for medical and psychiatric history, sessions that are monitored from start to finish, and a plan for what comes next after the initial series. Symptom questionnaires are usually part of that plan, because they let a person and a physician see the pattern rather than guess at it.
Honest limits
Ketamine does not work for everyone, and nobody can promise a particular outcome. The same is true of SPRAVATO, TMS, and medications. What a clinic can promise is a clear explanation, careful supervision, and a plan that adjusts when something is not working.
Making the first step simple
For most people, the first step is an evaluation. It is a conversation with a psychiatrist about symptoms, history, past treatments, and goals. It does not commit anyone to a treatment. It simply replaces guesswork with a plan, including a plain statement of which options are approved and which are off-label.
How care works at TMS Therapy Centers Colorado
TMS Therapy Centers Colorado is a physician-led clinic founded by William Kromka, MD, a board-certified psychiatrist. Ketamine therapy is offered off-label under physician supervision, and SPRAVATO is given in a certified setting. The first step is an evaluation, in person or by private video from anywhere in Colorado. No referral is needed, most major insurance plans are accepted, and benefits are verified before treatment begins. To begin, call 720-500-7873.